Sign in
CompletedNo phase

Precision Application of Clostridium Butyricm of Clinical Research on Osteoarthritis

Key facts

Who runs it
China Medical University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
83 people enrolled
Started
1 Apr 2023
Ended
29 Feb 2024
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
  • Visual Analogue Scale (VAS)
  • Kellgren Lawrence Grading Scale (KL score)
  • Quality of Life Questionnaires and Assessments:
Record updated
26 August 2024

Who can take part

Age
55 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • A. Patients aged 55 to 75 years old with degenerative arthritis, diagnosed by a physician as suitable for participation in this experiment
  • Patients with early-stage degenerative arthritis symptoms, as interpreted by X-ray using the Kellgren Lawrence Grading Scale at grade 1 or 2, and determined by a physician to not require long-term treatment
  • Patients with a high pain index when the knee is extended 40-70 mm
  • Patients who feel knee pain, primarily those with a high Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index score (pain scale score >2.0 or total WOMAC scale score >12)

Who cannot take part

  • Patients who have taken steroid medication for the treatment of degenerative arthritis
  • A. Patients with a history of knee joint trauma or knee joint surgery (including arthroscopic surgery)
  • Patients with severe cardiovascular, cerebrovascular, rheumatic, or psychiatric diseases
  • Patients with infectious diseases or acute infections (e.g., fever, localized inflammation, abscess)
  • Patients with systemic or metabolic diseases, or progressive bone degeneration caused by medication
  • Cancer patients
  • Patients with joint pain caused by other factors

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Osteoarthritis (OA) is a common joint disease worldwide. The main symptom is that the mechanical wear of the cartilage in the joint and leads to the abnormal proliferation of the surrounding bone and synovial tissue with the chronic inflammation and the narrowing of the joint cavity. The prevalence of OA is increasing due to population increasing and aging, and there are currently about 400 million OA patients in worldwide. The treatment methods of osteoarthritis are mainly divided into medicine and non-medicine therapy. The major function of medicine therapy is to reduce pain and the arthroscopic surgery (arthroscopy) is main treatment of non-medicine therapy. Thus, in this project the investigators will mainly focus on the precise application of Clostridium butyricum on OA and the investigators' previous study successfully demonstrated the therapeutic effects of Clostridium butyricum on OA animal model. Therefore, will test the clinical effects of OA patient with Clostridium butyricum treatment, and whether it is also possible to improve the symptom of OA patients.

The 2 groups in the trial

  • Group A (placebo)Placebo, for comparison

    Treatment: Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Visual Analogue Scale (VAS), Kellgren Lawrence Grading Scale (KL score), and Quality of Life Questionnaires and Assessments:

  • Group B (Treatment)Treatment being tested

    Treatment: Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Visual Analogue Scale (VAS), Kellgren Lawrence Grading Scale (KL score), and Quality of Life Questionnaires and Assessments:

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
26 August 2024